Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  Row 11 is based on the quotient obtained by dividing (a) the aggregate number of Common Stock beneficially owned by Oxford Science Enterprises plc by (b) the 68,737,224 total shares of Common Stock outstanding as of September 26, 2025, as disclosed by the Issuer in its prospectus supplement dated September 24, 2025, and filed with the SEC on September 25, 2025.


SCHEDULE 13G



 
Oxford Science Enterprises plc
 
Signature:/s/ Jim Wilkinson
Name/Title:Chief Financial Officer
Date:10/01/2025